000143561 001__ 143561
000143561 005__ 20240229112557.0
000143561 0247_ $$2doi$$a10.1016/j.ctim.2019.02.006
000143561 0247_ $$2pmid$$apmid:30935537
000143561 0247_ $$2ISSN$$a0965-2299
000143561 0247_ $$2ISSN$$a1873-6963
000143561 0247_ $$2altmetric$$aaltmetric:55433113
000143561 037__ $$aDKFZ-2019-01142
000143561 041__ $$aeng
000143561 082__ $$a610
000143561 1001_ $$aMokhtarzade, Motahare$$b0
000143561 245__ $$aWeight control and physical exercise in people with multiple sclerosis: Current knowledge and future perspectives.
000143561 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2019
000143561 3367_ $$2DRIVER$$aarticle
000143561 3367_ $$2DataCite$$aOutput Types/Journal article
000143561 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1565255419_15378$$xReview Article
000143561 3367_ $$2BibTeX$$aARTICLE
000143561 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143561 3367_ $$00$$2EndNote$$aJournal Article
000143561 520__ $$aThere is extensive data supporting a high prevalence of both overweight and obesity status in people with multiple sclerosis, and increases in body mass index has been associated with an increased risk of multiple sclerosis. Body composition may influence the course, treatment and management of multiple sclerosis. One proposed strategy for managing overweight and obesity status and associated secondary effects in people with multiple sclerosis involves increasing the levels of physical activity. In fact, increased levels of physical activity affect various physiological (endurance capacity, strength, balance) and biological processes (fat oxidation, insulin sensitivity, anti-inflammation, neurotrophic factors) which are known to be dysfunctional in multiple sclerosis and which may worsen with increases in obesity. When designing personalized exercise programs it should be kept in mind that current exercise recommendations for people with multiple sclerosis should exceed energy expenditure recommendations to efficiently counteract weight gain. Therefore, it is necessary to consider body composition as a primary endpoint in experimental studies. In addition, designing guidelines for weight control or weight loss in people MS is needed. The most comprehensive weight management guidelines are outlined in the American College of Sports Medicine Position Statement, which recommends between 150-250 min per week of moderate-intensity physical activity for preventing weight gain, and between 225-420 min per week of moderate-intensity physical activity for weight loss. These recommendations seem applicable for people with multiple sclerosis.
000143561 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000143561 588__ $$aDataset connected to CrossRef, PubMed,
000143561 7001_ $$aAgha-Alinejad, Hamid$$b1
000143561 7001_ $$aMotl, Robert W$$b2
000143561 7001_ $$aNegaresh, Raoof$$b3
000143561 7001_ $$aBaker, Julien S$$b4
000143561 7001_ $$0P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aZimmer, Philipp$$b5$$eLast author$$udkfz
000143561 773__ $$0PERI:(DE-600)2048809-9$$a10.1016/j.ctim.2019.02.006$$gVol. 43, p. 240 - 246$$p240 - 246$$tComplementary therapies in medicine$$v43$$x0965-2299$$y2019
000143561 909CO $$ooai:inrepo02.dkfz.de:143561$$pVDB
000143561 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d05b24af674d8ef2c455634434b67770$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000143561 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000143561 9141_ $$y2019
000143561 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000143561 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143561 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCOMPLEMENT THER MED : 2017
000143561 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143561 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143561 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143561 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143561 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143561 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000143561 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143561 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000143561 980__ $$ajournal
000143561 980__ $$aVDB
000143561 980__ $$aI:(DE-He78)C110-20160331
000143561 980__ $$aUNRESTRICTED